Vasodilator prostanoids compensate for attenuated nitric oxide mediated vasodilation in type 1 diabetes

Abstract

Background Previous research examining endothelial function and the biochemical pathways mediating vasodilation in type 1 diabetes has been conflicting. Both impaired and preserved nitric oxide (NO) mediated vasodilation have been reported whilst some authors have suggested enhanced vasodilator prostanoid (P) activity. The aim of this study was to determine the relative contributions of NO and P to endothelial function in a homogenous group of type 1 diabetic patients free of other confounding factors that may influence vascular behaviour.^f ^

Methods and results Endothelial function was assessed using forearm venous plethysmography in 16 patients with uncomplicated type 1 (duration of diabetes 16.8±2.5 years (mean±SEM), HbA_1C 7.53±0.21% ) and 15 non-diabetic age and sex matched healthy control subjects. Forearm responses to the endothelium-dependent vasodilator, acetylcholine (ACh) (7.5, 15 and 30 µg/min), were recorded at baseline and after intra-arterial infusion of L-NMMA (a NO synthase inhibitor). Responses to ACh were re-examined following co-infusion of L-NMMA and indomethacin (a cyclo-oxygenase inhibitor). Responses to ACh were calculated as areas under the curve (AUC). At baseline vasodilator responses to ACh were similar (p=0.3) in diabetic and non-diabetic subjects. However, L-NMMA reduced ACh mediated responses to a lesser extent in diabetic subjects than control subjects (3±6% versus 18±3%; p<0.03 respectively). Co-infusion with indomethacin further reduced blood flow, but the relative decrease in AUC was greater in the diabetic group (28±3% vs. 14±3%; p<0.001). The contribution of biochemical pathways other than NO and P were similar in both diabetic and control groups (69±7% vs. 68±4%; p=0.45).

Conclusions Vasodilator responses to ACh were unchanged in type 1 diabetes but this was reliant up on enhanced P mediated activity compensating for attenuated NO activity. Furthermore, vasoactive substances in addition to NO and P contribute significantly to vascular tone in both diabetic and non-diabetic subjects.

Keywords

acetylcholine endothelium nitric oxide prostaglandins type 1 diabetes.

Get full access to this article

View all access options for this article.

References

Krolewski AS , Kosinski EJ , Warram JH et al. Magnitude and Determinants of Coronary Artery Disease in Juvenile-Onset, Insulin-Dependent Diabetes Mellitus. Am J Cardiol 1987;59:750-5.

Vallance P. , Collier J. , Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii 1989:997-1000.

Calver A. , Collier J. , Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54.

Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol 1997;79(12B):2-9.

Neunteufl T. , Heher S. , Katzenschlager R. et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10.

Meeking DR , Browne DL , Allard S. et al. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects . Diabetes Care 2000;23:1840-3.

Wotherspoon F. , Laight DW , Browne DL et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria . Diabetic Med 2006;23:1350-6.

O'Driscoll G. , Green D. , Rankin J. et al. Improvements in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997;100:678-84.

Johnstone MT , Creager SJ , Scales KM et al. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 1993:88:2510-16.

10.

Stehouwer CD , Lambert J. , Donker AJ , van Hinsbergh VW Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997 ;34(1):55-68.

11.

Elliott TG , Cockcroft JR , Groop P-H. et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993;85:687-93.

12.

O'Byrne SO , Forte P. , Roberts J. et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion . Diabetes 2000;49:857-62.

13.

Duffy SJ , New G. , Tran BT et al. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999;276(2 Pt 2):H663-H670.

14.

Tesfamariam B. , Brown ML , Deykin D. , Cohen RA Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990;85:929-32.

15.

Dogra G. , Rich L. , Stanton K. , Watts GF Endothelium-dependent and independent vasodilation studied at normoglycaemia in Type 1 diabetes mellitus with and without microalbuminuria. Diabetologia 2001;44:593-601.

16.

Vallance P. , Collier J. , Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989 ; 2:997-1000.

17.

Dawes M. , Chowienczyk PJ , Ritter JM Effects of inhibition of Tthe Larginine / nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997;95:2293-7.

18.

Timimi FK , Ting HH , Hayley et al. Vitamin C improves G endotheliumdependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-7.

19.

Macklin AV , Viberti GC , Ritter J. Forearmblood Y flow in type 1 diabetics during systemic hyperglycemia . Diabetologia 1998;41(1):A310.

20.

Rubanyi GM , McKinney M. , Vanhoutte PM Biphas A ic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterisation of muscurinic receptors . J Pharmacol Exp Ther 1987;240:802-08. OD

21.

Chan NN , Vallance P. , Colhoun HM Nitric oxide and vascular responses in Type I diabetes. Diabetologia 2000;43:137-47.

22.

van Veen S. , Chang PC Prostaglandin and nitric oxide mediate insulininduced vasodilation in the human forearm. Cardiovasc Res 1997;34:223-9.

23.

Dawes M. , Chowienczyk PJ , Ritter JM Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature . Br J Pharmacol 2001;134:939-44.

24.

Skyrme-Jones Rap , O'Brien RC , Meredith IT Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type 1 diabetes mellitus. Clinical Science 2000;99:383-92.

25.

Schade DS , Eaton RP , Freidman N. , Spencer W. The intravenous, intraperitoneal and subcutaneous routes of insulin delivery in diabetic man. Diabetes 1979;28:1069-72.

26.

Gonzalez E. , Rosello-Catafau J. , Jawerbaum A. et al. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway. Prostaglandins Leukot Essent Fatty Acids 2001;64:311-16.

27.

Honing MLH , Smits P. , Morrison PJ et al. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarisation. Hypertension 2000; 35:1314-18.

28.

Taddei S. , Versari D. , Cipriano A. et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. JACC 2006;48:508-15.

29.

Rajagopalan S. , Kurz S. , Munzel T. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations in vasomotor tone . J Clin Invest 1996;97:1916-23.

30.

Cardillo C. , Kilcoyne CM , Cannon RO Det al. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000;35:1237-41.

31.

Drury PL , Smith GM , Ferriss JB Increased vasopressor responsiveness to angiotensin II in type 1(insulin dependent) diabetic patients without complications. Diabetologia 1984;27:174-9.

32.

McIntyre C. , Hadoke PWF , Williams BC et al. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type 1 diabetes. Clinical Science 2001;100:311-18.

33.

Butler R. , Morris AD , Burchell B. , Struthers AD DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-8.dysnction in normal J, humans, Hypertension T. Gene transfer of endothelial

34.

Zanetti M. , Sato J. , Katusic ZS , O'Brien T. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits. Diabetologia 2000;43:340-7.

35.

Bush DE , Jones CE , Bass KM et al. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552-8.

36.

Ishii H. , Jirousek MR , Koya D. et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC-beta inhibitor. Science 1996;272:728-31.

37.

Mutus B. , Rabini RA , Staffolani R. et al. Homocysteine-induced inhibition of nitric oxide production study on healthy and diabetic subjects. Diabetologia 2001;44:979-82.